Godoy Pere, Martínez-Baz Iván, Parron Ignasi, García-Cenoz Manuel, Ferras Joaquim, Carol Mònica, Bes Nuria, Guillaumes Montserrat, Godoy Sofia, Toledo Diana, Follia Núria, Miret Carme, Pardos Jessica, Alsedà Miquel, Plans-Rubio Pedro, Sanz Inma, Sala Maria-Rosa, Caylà Joan A, Mendioroz Jacobo, Muñoz-Almagro Carmen, Castilla Jesús, Domínguez Ángela
Institut de Recerca Biomédica (IRB Lleida), Universitat de Lleida, 25006 Lleida, Spain.
CIBER de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Vaccines (Basel). 2024 Feb 26;12(3):240. doi: 10.3390/vaccines12030240.
The aim of this study was to evaluate the impact of index case vaccination on SARS-CoV-2 transmission to household contacts. In our epidemiological cohort study (May 2022-November 2023), we surveyed registered index case vaccination status and test results for contacts (testing on day 0, and on day 7 for negative contacts) and calculated the secondary attack rate (SAR), i.e., newly infected contacts/susceptible included contacts. The association of the independent variable, index case COVID-19 vaccination (yes/no), with household contact infection was determined using the adjusted odds ratio (aOR) and its 95% confidence interval (CI). We recorded 181 index cases and 314 contacts, of whom 250 agreed to participate; 16 contacts were excluded upon testing positive on day 0. Of the 234 included contacts, 49.1% were women, and the mean (SD) age was 51.9 (19.8) years. The overall SAR of 37.2% (87/234) was lower in the contacts of both vaccinated index cases (34.9% vs. 63.2%; = 0.014) and index cases with a previous SARS-CoV-2 infection history (27.0% vs. 46.3%; = 0.002). Index case vaccination showed a protective effect against infection for their household contacts (aOR = 0.21; 95% CI: 0.07, 0.67). The household SAR was high when the Omicron variant circulated. Vaccinated index cases were less likely to transmit SARS-CoV-2 to their contacts.
本研究的目的是评估首例病例接种疫苗对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播给家庭接触者的影响。在我们的流行病学队列研究(2022年5月至2023年11月)中,我们调查了首例病例的疫苗接种状况以及接触者的检测结果(第0天检测,阴性接触者在第7天检测),并计算了二代发病率(SAR),即新感染的接触者/纳入的易感接触者。使用调整后的优势比(aOR)及其95%置信区间(CI)确定自变量首例病例的2019冠状病毒病疫苗接种(是/否)与家庭接触者感染之间的关联。我们记录了181例首例病例和314名接触者,其中250人同意参与;16名接触者在第0天检测呈阳性后被排除。在纳入的234名接触者中,49.1%为女性,平均(标准差)年龄为51.9(19.8)岁。在接种疫苗的首例病例的接触者(34.9%对63.2%;P = 0.014)和有既往SARS-CoV-2感染史的首例病例的接触者(27.0%对46.3%;P = 0.002)中,总体二代发病率37.2%(87/234)较低。首例病例接种疫苗对其家庭接触者的感染具有保护作用(aOR = 0.21;95%CI:0.07,0.67)。当奥密克戎变异株传播时,家庭二代发病率较高。接种疫苗的首例病例将SARS-CoV-2传播给其接触者的可能性较小。